Treatment of benign prostatic hyperplasia and occurrence of prostatic surgery and acute urinary retention: A population-based cohort study in the Netherlands

European Urology

Volumn 47, Issue 4, 2005, Pages 505-510

  Souverein, P C ^a   Van Riemsdijk, M M ^b   De La Rosette, J J M C H ^c   Opdam, P C E ^d   Leufkens, H G M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b GLAXOSMITHKLINE   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d Zorggroep Almere   (Netherlands)

Author keywords

5 reductase inhibitors; Benign prostatic hyperplasia; Cohort study; Database; adrenoceptor antagonist

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; ENZYME INHIBITOR; FINASTERIDE; OXIDOREDUCTASE; PRAZOSIN; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TERAZOSIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; HEALTH HAZARD; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD; NETHERLANDS; PARAMETER; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE SURGERY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; URINE RETENTION;

EID: 14844352457     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.11.001     Document Type: Article

References (14)

1. S.J. Berry, D.S. Coffey, P.C. Walsh, and L.L. Ewing The development of human benign prostatic hyperplasia with age J Urol 132 3 1984 474 479
2. W.M. Garraway, G.N. Collins, and R.J. Lee High prevalence of benign prostatic hypertrophy in the community Lancet 338 8765 1991 469 471
3. B. Djavan, and M. Marberger A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction Eur Urol 36 1 1999 1 13
4. G.J. Gormley, E. Stoner, R.C. Bruskewitz, J. Imperato-McGinley, P.C. Walsh, and J.D. McConnell The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group N Engl J Med 327 17 1992 1185 1191
5. J.D. McConnell, J.D. Wilson, F.W. George, J. Geller, F. Pappas, and E. Stoner Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia J Clin Endocrinol Metab 74 3 1992 505 508
6. P. Boyle, A.L. Gould, and C.G. Roehrborn Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials Urology 48 3 1996 398 405
7. P.C. Souverein, J.A. Erkens, J.J. de la Rosette, H.G. Leufkens, and R.M. Herings Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery Eur Urol 43 5 2003 528 534
8. G.S. Sonke, D. Kolman, J.J. de la Rosette, L.H. Donkers, P. Boyle, and L.A. Kiemeney Prevalence of lower urinary tract symptoms in men and its influence on their quality of life: Boxmeer Study Ned Tijdschr Geneeskd 144 53 2000 2558 2563
9. M.H. Blanker, F.P. Groeneveld, A. Prins, R.M. Bernsen, A.M. Bohnen, and J.L. Bosch Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status BJU Int 85 6 2000 665 671
10. K.M. Verhamme, J.P. Dieleman, G.S. Bleumink, J. van der Lei, M.C. Sturkenboom, and W. Artibani Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care-the Triumph project Eur Urol 42 4 2002 323 328
11. J.D. McConnell, C.G. Roehrborn, O.M. Bautista, G.L. Andriole Jr., C.M. Dixon, and J.W. Kusek The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Engl J Med 349 25 2003 2387 2398
12. P. Boyle, C. Roehrborn, R. Harkaway, J. Logie, J. de la Rosette, and M. Emberton 5-alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery Eur Urol 45 5 2004 620 626 [Discussion 626-7]
13. J.A. Erkens, and R.M. Herings Drug and surgical treatment of BPH 2002 PHARMO Institute for Drug Outcomes Research Utrecht
14. A.E. Vlug, J. van der Lei, B.M. Mosseveld, M.A. van Wijk, P.D. van der Linden, and M.C. Sturkenboom Postmarketing surveillance based on electronic patient records: the IPCI project Methods Inf Med 38 4-5 1999 339 344